东亚人群中降脂治疗对冠状动脉斑块的影响：越低越好。 - Suppr

Suppr

超能文献

Lipid Lowering Therapy on Coronary Artery Plaque in East Asians: The Lower the Better.

作者信息

Franchin Luca, Bertaina Maurizio

机构信息

Department of Cardiology, San Giovanni Bosco Hospital, ASL Città di Torino, Udine, Italy.

出版信息

JACC Asia. 2025 Aug;5(8):1048-1049. doi: 10.1016/j.jacasi.2025.06.008.

DOI:10.1016/j.jacasi.2025.06.008

PMID:40774752

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12426833/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cecc/12426833/2e9a89efcb47/ga1.jpg

相似文献

Lipid Lowering Therapy on Coronary Artery Plaque in East Asians: The Lower the Better.东亚人群中降脂治疗对冠状动脉斑块的影响：越低越好。

JACC Asia. 2025 Aug;5(8):1048-1049. doi: 10.1016/j.jacasi.2025.06.008.

The Effect of Lipid-Lowering Therapy on Coronary Artery Plaque in East Asia Population.降脂治疗对东亚人群冠状动脉斑块的影响。

JACC Asia. 2025 Aug;5(8):1032-1047. doi: 10.1016/j.jacasi.2025.05.016. Epub 2025 Jul 15.

Comparison of coronary atherosclerotic plaque progression in East Asians and Caucasians by serial coronary computed tomographic angiography: A PARADIGM substudy.通过系列冠状动脉计算机断层扫描血管造影术比较东亚人和高加索人的冠状动脉粥样硬化斑块进展：一项PARADIGM子研究。

J Cardiovasc Comput Tomogr. 2022 May-Jun;16(3):222-229. doi: 10.1016/j.jcct.2021.09.012. Epub 2021 Oct 14.

Lipid-lowering therapies and long-term stroke prevention in East Asians: A systematic review and meta-analysis of randomized controlled trials.东亚人群的降脂治疗与长期卒中预防：随机对照试验的系统评价和荟萃分析

Int J Stroke. 2025 Jan;20(1):29-41. doi: 10.1177/17474930241264686. Epub 2024 Jul 31.

Effect of lipid-lowering therapy on carotid plaque burden in older adults.降脂治疗对老年人颈动脉斑块负担的影响。

J Neurol Sci. 2024 Jun 15;461:123023. doi: 10.1016/j.jns.2024.123023. Epub 2024 Apr 30.

Impact of PCSK9 inhibitors on coronary atheroma phenotype following myocardial infarction: insights from intravascular imaging.心梗后 PCSK9 抑制剂对冠状动脉粥样硬化斑块表型的影响：血管内影像学的见解。

Curr Opin Cardiol. 2023 Nov 1;38(6):504-508. doi: 10.1097/HCO.0000000000001080. Epub 2023 Sep 25.

Position Statement on Antiplatelet Therapy for East Asians With Coronary Artery Disease: 2025 Update.《2025年东亚冠状动脉疾病患者抗血小板治疗立场声明更新版》

JACC Asia. 2025 Jul;5(7):821-846. doi: 10.1016/j.jacasi.2025.04.010.

Coronary plaque and clinical characteristics of South Asian (Indian) patients with acute coronary syndromes: An optical coherence tomography study.南亚（印度）急性冠脉综合征患者的冠状动脉斑块和临床特征：一项光学相干断层扫描研究。

Int J Cardiol. 2021 Nov 15;343:171-179. doi: 10.1016/j.ijcard.2021.08.048. Epub 2021 Sep 3.

Statin treatment and carotid plaque composition: a review of clinical studies.他汀类药物治疗与颈动脉斑块成分：临床研究综述。

Curr Vasc Pharmacol. 2014 May;12(3):518-26. doi: 10.2174/15701611113119990134.

Lesion-Level Effects of LDL-C-Lowering Therapy in Patients With Acute Myocardial Infarction: A Post Hoc Analysis of the PACMAN-AMI Trial.急性心肌梗死患者低密度脂蛋白胆固醇降低治疗的病变水平效应：PACMAN-AMI试验的事后分析

JAMA Cardiol. 2024 Dec 1;9(12):1082-1092. doi: 10.1001/jamacardio.2024.3200.

本文引用的文献

The Effect of Lipid-Lowering Therapy on Coronary Artery Plaque in East Asia Population.降脂治疗对东亚人群冠状动脉斑块的影响。

JACC Asia. 2025 Aug;5(8):1032-1047. doi: 10.1016/j.jacasi.2025.05.016. Epub 2025 Jul 15.

Enhanced Plaque Stabilization Effects of Alirocumab　- Insights From Artificial Intelligence-Aided Optical Coherence Tomography Analysis of the Alirocumab for Thin-Cap Fibroatheroma in Patients With Coronary Artery Disease Estimated by Optical Coherence Tomography (ALTAIR) Study.依洛尤单抗增强斑块稳定性作用的人工智能辅助光学相干断层成像分析——来自冠状动脉粥样硬化患者薄帽纤维粥样瘤的依洛尤单抗评估的光学相干断层成像（ALTAIR）研究。

Circ J. 2024 Oct 25;88(11):1809-1818. doi: 10.1253/circj.CJ-24-0480. Epub 2024 Sep 21.

Global Trends in Atherosclerotic Cardiovascular Disease.全球动脉粥样硬化性心血管疾病趋势

Clin Ther. 2023 Nov;45(11):1087-1091. doi: 10.1016/j.clinthera.2023.09.020. Epub 2023 Oct 30.

Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects　- A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial.依洛尤单抗长期使用的疗效和安全性：在高风险受试者中进行的用前蛋白转化酶枯草溶菌素 9 抑制剂进一步心血管结局研究（FOURIER）试验的亚组分析。

Circ J. 2021 Oct 25;85(11):2063-2070. doi: 10.1253/circj.CJ-20-1051. Epub 2021 May 15.

Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol : A meta-analysis of trials with East Asian populations.瑞舒伐他汀与阿托伐他汀降低低密度脂蛋白胆固醇的疗效及安全性：东亚人群试验的荟萃分析

Herz. 2020 Sep;45(6):594-602. doi: 10.1007/s00059-018-4767-2. Epub 2018 Nov 27.

Low-density lipoprotein cholesterol target attainment in patients with stable or acute coronary heart disease in the Asia-Pacific region: results from the Dyslipidemia International Study II.亚太地区稳定性或急性冠心病患者的低密度脂蛋白胆固醇目标达标情况：血脂异常国际研究 II 的结果。

Eur J Prev Cardiol. 2018 Dec;25(18):1950-1963. doi: 10.1177/2047487318798927. Epub 2018 Sep 10.

Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.依折麦布与阿托伐他汀双重降脂策略对经皮冠状动脉介入治疗患者冠状动脉斑块逆转的影响：多中心随机对照 PRECISE-IVUS 试验。

J Am Coll Cardiol. 2015 Aug 4;66(5):495-507. doi: 10.1016/j.jacc.2015.05.065.

The difference between Asian and Western in the effect of LDL-C lowering therapy on coronary atherosclerotic plaque: a meta-analysis report.亚洲人与西方人在低密度脂蛋白胆固醇（LDL-C）降低治疗对冠状动脉粥样硬化斑块影响方面的差异：一项荟萃分析报告

BMC Cardiovasc Disord. 2015 Feb 14;15:6. doi: 10.1186/1471-2261-15-6.

Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.急性冠状动脉综合征患者的早期他汀类药物治疗：通过冠状动脉事件后半年内的系列容积血管内超声分析证明对动脉粥样硬化病变的有益作用：ESTABLISH研究

Circulation. 2004 Aug 31;110(9):1061-8. doi: 10.1161/01.CIR.0000140261.58966.A4. Epub 2004 Aug 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验